Poly Medicure Limited

BSE: 531768 NSE: POLYMED
Poly Medicure Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN L40300DL1995PLC066923 Incorporated 30 March 1995 ROC Delhi HQ New Delhi, Delhi, India
Active Listed - NSE: POLYMED · BSE: 531768 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹1,875.26 Cr
▲ 12.3% YoY
EBITDA · FY 2026
₹562.4 Cr
▲ 3.77% YoY
Net profit · FY 2026
₹320.73 Cr
▼ 5.27% YoY
Authorised capital
₹60 Cr
Registered with MCA
Paid-up capital
₹50.68 Cr
Issued & subscribed
Open charges
₹479.5 Cr
Satisfied ₹140.2 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
2,683
Latest available

About Poly Medicure Limited

Data last updated: 06 March 2026

Poly Medicure Limited is a public limited company based in New Delhi, Delhi, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 30 March 1995, the company has been in operation for over 31 years.

Registered with ROC Delhi under CIN L40300DL1995PLC066923. Listed on BSE: 531768 and NSE: POLYMED.

Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹50.68 Cr. Formerly known as Polymedicure Limited. It is led by directors including Vishal Gupta and Alessandro Balboni.

Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,758.96 Cr, a growth of 23% compared to the previous year.

The company has a workforce of approximately 2,683 employees as per the latest available data.

The company is associated with 1 brand - Polymedicure. As per MCA filings, the company has open charges of ₹479.5 Cr and satisfied charges of ₹140.2 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website polymedicure.com.

Company Details of Poly Medicure Limited
CIN L40300DL1995PLC066923
Registration Number 066923
Incorporation Date 30 March 1995
ROC Delhi
Listing Status Listed (BSE: 531768, NSE: POLYMED)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Himanshu Baid Managing Director Rishi Baid Whole-Time Director Pankaj Kumar Gupta Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    polymedicure.com
  • Social Media
  • Registered Address
    Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020
  • Industry
    Healthcare, Medical & Laboratory Equipment
Company report
Poly Medicure Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Poly Medicure Limited report

Financials, compliance, directors, charges, ownership and filings for Poly Medicure Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Poly Medicure Limited

Poly Medicure Limited has one previous CIN (Corporate Identification Number): L74899DL1995PLC066923. The current CIN is L40300DL1995PLC066923, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L40300DL1995PLC066923 Current
L74899DL1995PLC066923 Previous

Associated Brands with Poly Medicure Limited

Poly Medicure Limited operates one associated brand: Polymedicure. These brands represent Poly Medicure Limited's diversified market presence and brand portfolio.

Brand Description Website
Polymedicure
Medical devices for oncology, dialysis, and respiratory care are manufactured. polymedicure.com

Business Activity of Poly Medicure Limited

Poly Medicure Limited is engaged in the principal business activity of manufacturing, with detailed activities including plastic products, non-metallic mineral products, rubber products, fabricated metal products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C8 Plastic products, non-metallic mineral products, rubber products, fabricated metal products *********

Auditor Details of Poly Medicure Limited

Poly Medicure Limited is audited by Doogar & Associates (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Doogar & Associates (ICAI peer reviewed, certificate valid till 2028-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Poly Medicure Limited

Poly Medicure Limited is currently managed by 16 directors, with 22 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Vishal Gupta
Also directs: Woodstory Llp, Semac Construction Limited, Ashiana Housing Limited and 5 more
Director 28 Oct 2024 1 Years 8 Months Current
Alessandro Balboni Director 10 May 2018 8 Years 1 Months Current
Ambrish Mithal Director 04 Aug 2022 3 Years 11 Months Current
Vimal Bhandari
Also directs: Kec International Limited, Escorts Kubota Limited, Jk Lakshmi Cement Limited and 1 more
Director 22 Jul 2024 1 Years 11 Months Current
Sonal Mattoo
Also directs: Syntegon Telstar India Private Limited, Pramerica Life Insurance Limited
Director 29 Aug 2020 5 Years 10 Months Current
Sandeep Bhargava Additional Director 25 Feb 2017 9 Years 4 Months Current
Showing 6 of 16 current directors. View all directors

Financials of Poly Medicure Limited FY 2026 filings available

Poly Medicure Limited reported revenue of ₹1,875.26 Cr (up 12.3% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹1,875.26 Cr ▲ 12.3%
Profit · FY 2026
₹320.73 Cr ▼ 5.27%
EBITDA · FY 2026
₹562.4 Cr ▲ 3.77%
Revenue₹ Cr · Consolidated01,0002,000FY 2020: ₹687 Cr687FY 2020FY 2021: ₹786 Cr · +14.4% YoY786+14.4%FY 2021FY 2022: ₹923 Cr · +17.4% YoY923+17.4%FY 2022FY 2023: ₹1,115 Cr · +20.8% YoY1,115+20.8%FY 2023FY 2024: ₹1,376 Cr · +23.4% YoY1,376+23.4%FY 2024FY 2025: ₹1,670 Cr · +21.4% YoY1,670+21.4%FY 2025FY 2026: ₹1,875 Cr · +12.3% YoY1,875+12.3%FY 2026
Net Profit₹ Cr · Consolidated0200400FY 2020: ₹96 Cr95.9FY 2020FY 2021: ₹136 Cr · +41.7% YoY136+41.7%FY 2021FY 2022: ₹147 Cr · +7.8% YoY147+7.8%FY 2022FY 2023: ₹179 Cr · +22.4% YoY179+22.4%FY 2023FY 2024: ₹258 Cr · +44.1% YoY258+44.1%FY 2024FY 2025: ₹339 Cr · +31.1% YoY339+31.1%FY 2025FY 2026: ₹321 Cr · -5.3% YoY321-5.3%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400600Q1'25: ₹385 Cr · +19.9% YoY385+19.9%Q1'25Q2'25: ₹420 Cr · +24.5% YoY420+24.5%Q2'25Q3'25: ₹424 Cr · +24.9% YoY424+24.9%Q3'25Q4'25: ₹441 Cr · +16.6% YoY441+16.6%Q4'25Q1'26: ₹403 Cr · +4.8% YoY403+4.8%Q1'26Q2'26: ₹444 Cr · +5.7% YoY444+5.7%Q2'26Q3'26: ₹494 Cr · +16.4% YoY494+16.4%Q3'26Q4'26: ₹535 Cr · +21.3% YoY535+21.3%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,875.26 Cr ₹1,669.83 Cr ₹1,375.8 Cr ₹1,115.23 Cr ₹923.06 Cr ₹786.47 Cr ₹687.24 Cr
Other Income ₹120.08 Cr ₹89.13 Cr ₹58.75 Cr ₹36.19 Cr ₹37.9 Cr ₹18.42 Cr ₹18.46 Cr
Total Income ₹1,995.34 Cr ₹1,758.96 Cr ₹1,434.54 Cr ₹1,151.42 Cr ₹960.97 Cr ₹804.88 Cr ₹705.7 Cr
Cost of Materials Consumed ₹599.39 Cr ₹571.36 Cr ₹464.78 Cr ₹424.31 Cr ₹352.37 Cr ₹266.58 Cr ₹225.22 Cr
Purchases of Stock-in-Trade ₹5.06 Cr ₹7.94 Cr ₹7.02 Cr ₹5.21 Cr ₹10.66 Cr ₹3.08 Cr ₹70.55 Lakh
Changes in Inventories -₹7.64 Cr -₹24.61 Cr ₹10.8 Cr -₹23.65 Cr -₹14.95 Cr -₹7.81 Cr -₹8.88 Cr
Employee Benefit Expense ₹402.26 Cr ₹301.53 Cr ₹245.91 Cr ₹202.75 Cr ₹163.62 Cr ₹141.76 Cr ₹138.76 Cr
Finance Costs ₹18.29 Cr ₹12 Cr ₹11.3 Cr ₹8.84 Cr ₹4.25 Cr ₹8.51 Cr ₹18.31 Cr
Depreciation & Amortisation ₹115.52 Cr ₹82.64 Cr ₹63.93 Cr ₹57.17 Cr ₹53.95 Cr ₹47.52 Cr ₹40.53 Cr
Other Expenses ₹433.88 Cr ₹360.77 Cr ₹289.06 Cr ₹241.22 Cr ₹198.27 Cr ₹168.49 Cr ₹167.47 Cr
Total Expenses ₹1,566.75 Cr ₹1,311.62 Cr ₹1,092.8 Cr ₹915.85 Cr ₹768.17 Cr ₹628.14 Cr ₹582.12 Cr
Profit Before Exceptional Items & Tax ₹428.59 Cr ₹447.34 Cr ₹341.74 Cr ₹235.56 Cr ₹192.8 Cr ₹176.74 Cr ₹123.58 Cr
Exceptional Items -₹6.8 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹421.79 Cr ₹447.34 Cr ₹341.74 Cr ₹235.56 Cr ₹192.8 Cr ₹176.74 Cr ₹123.58 Cr
Total Tax Expense ₹106.74 Cr ₹113.96 Cr ₹86.01 Cr ₹58.21 Cr ₹48.74 Cr ₹44.18 Cr ₹29.85 Cr
Net Profit ₹320.73 Cr ₹338.56 Cr ₹258.26 Cr ₹179.28 Cr ₹146.51 Cr ₹135.87 Cr ₹95.88 Cr
  attributable to Owners ₹322.14 Cr ₹338.56 Cr ₹258.26 Cr ₹179.28 Cr - - ₹0
  attributable to NCI -₹1.41 Cr ₹0 ₹0 ₹0 - - ₹0
Other Comprehensive Income ₹46.49 Cr -₹1.35 Cr -₹88.36 Lakh ₹40.61 Lakh ₹23.71 Lakh ₹10.46 Lakh ₹28.58 Lakh
Total Comprehensive Income ₹367.22 Cr ₹337.2 Cr ₹257.38 Cr ₹179.69 Cr ₹146.74 Cr ₹135.98 Cr ₹96.16 Cr
EBITDA (computed) ₹562.4 Cr ₹541.97 Cr ₹416.97 Cr ₹301.57 Cr ₹251 Cr ₹232.78 Cr ₹182.42 Cr
Basic EPS ₹31.79 ₹34.13 ₹26.92 ₹18.69 ₹15.28 ₹15.25 ₹10.86
Diluted EPS ₹31.75 ₹34.11 ₹26.90 ₹18.67 ₹15.27 ₹15.24 ₹10.86
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,918.57 Cr ₹3,192.45 Cr ₹1,858.67 Cr ₹1,577.21 Cr
Non-current Assets ₹1,976.83 Cr ₹1,275.46 Cr ₹1,017.05 Cr ₹770.2 Cr
Current Assets ₹1,941.73 Cr ₹1,917 Cr ₹841.63 Cr ₹807.01 Cr
Property, Plant & Equipment ₹1,255.15 Cr ₹1,038.14 Cr ₹818.53 Cr ₹587.32 Cr
Inventories ₹433.84 Cr ₹285.57 Cr ₹221.03 Cr ₹208.65 Cr
Trade Receivables ₹531.17 Cr ₹349.73 Cr ₹269.94 Cr ₹235.43 Cr
Cash & Equivalents ₹51.23 Cr ₹8.7 Cr ₹12.05 Cr ₹7.06 Cr
Equity (Net Worth) ₹3,149.24 Cr ₹2,765.66 Cr ₹1,470.05 Cr ₹1,241.63 Cr
Equity Share Capital ₹50.68 Cr ₹50.66 Cr ₹47.99 Cr ₹47.97 Cr
Borrowings (Non-current) ₹52.09 Cr ₹0 ₹1.09 Cr ₹17.5 Cr
Borrowings (Current) ₹289.53 Cr ₹177.65 Cr ₹169.13 Cr ₹128.93 Cr
Total Debt (computed) ₹341.62 Cr ₹177.65 Cr ₹170.21 Cr ₹146.43 Cr
Current Liabilities ₹575.52 Cr ₹370.17 Cr ₹351.24 Cr ₹293.3 Cr
Total Liabilities ₹769.32 Cr ₹426.79 Cr ₹388.62 Cr ₹335.58 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹240.69 Cr ₹241.09 Cr ₹266.08 Cr ₹190.83 Cr ₹123.47 Cr
Investing Cash Flow -₹225.38 Cr -₹1,191.17 Cr -₹240.94 Cr -₹179.02 Cr -₹85.33 Cr
Financing Cash Flow ₹20.15 Cr ₹952.93 Cr -₹20.15 Cr -₹12.51 Cr -₹35.34 Cr
Capital Expenditure ₹308.39 Cr ₹324.99 Cr ₹277.02 Cr ₹239.27 Cr ₹155.58 Cr
Free Cash Flow (computed) -₹67.7 Cr -₹83.9 Cr -₹10.93 Cr -₹48.45 Cr -₹32.11 Cr
Dividends Paid ₹35.43 Cr ₹30.34 Cr ₹28.74 Cr ₹23.97 Cr ₹23.92 Cr
Net Change in Cash ₹36.85 Cr ₹2.85 Cr ₹4.99 Cr -₹69.5 Lakh ₹2.8 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹534.51 Cr ₹493.66 Cr ₹443.88 Cr ₹403.21 Cr ₹440.83 Cr ₹424.21 Cr ₹420.02 Cr ₹384.78 Cr ₹378.07 Cr ₹339.6 Cr ₹337.29 Cr ₹320.83 Cr
Other Income ₹17.76 Cr ₹26.26 Cr ₹33.94 Cr ₹41.69 Cr ₹24.31 Cr ₹21.8 Cr ₹26.1 Cr ₹16.92 Cr ₹14.97 Cr ₹16.57 Cr ₹14.09 Cr ₹13.11 Cr
Total Income ₹552.27 Cr ₹519.92 Cr ₹477.83 Cr ₹444.9 Cr ₹465.14 Cr ₹446.01 Cr ₹446.11 Cr ₹401.7 Cr ₹393.05 Cr ₹356.17 Cr ₹351.39 Cr ₹333.94 Cr
Cost of Materials Consumed ₹155.08 Cr ₹146.17 Cr ₹157.07 Cr ₹141.07 Cr ₹141.95 Cr ₹141.95 Cr ₹154.88 Cr ₹132.57 Cr ₹126.61 Cr ₹118.72 Cr ₹114.21 Cr ₹105.25 Cr
Purchases of Stock-in-Trade ₹1.38 Cr ₹1.58 Cr ₹1.23 Cr ₹85.85 Lakh ₹2.51 Cr ₹3.32 Cr ₹1.21 Cr ₹89.26 Lakh ₹1.35 Cr ₹1.05 Cr ₹2.85 Cr ₹1.77 Cr
Changes in Inventories ₹21.7 Cr ₹8.01 Cr -₹22.65 Cr -₹14.7 Cr ₹2.93 Cr ₹1.23 Cr -₹23.57 Cr -₹5.2 Cr ₹3.24 Cr -₹1.73 Cr ₹4.16 Cr ₹5.14 Cr
Employee Benefit Expense ₹126.14 Cr ₹115.2 Cr ₹88.83 Cr ₹75.11 Cr ₹78.89 Cr ₹77.89 Cr ₹78.09 Cr ₹70.79 Cr ₹69.44 Cr ₹60.4 Cr ₹58.32 Cr ₹57.75 Cr
Finance Costs ₹6.41 Cr ₹5.96 Cr ₹2.97 Cr ₹2.95 Cr ₹2.17 Cr ₹3.33 Cr ₹3.34 Cr ₹3.16 Cr ₹3.12 Cr ₹3.47 Cr ₹2.22 Cr ₹2.49 Cr
Depreciation & Amortisation ₹38.23 Cr ₹28.76 Cr ₹24.93 Cr ₹23.26 Cr ₹21.03 Cr ₹21.51 Cr ₹20.85 Cr ₹19.65 Cr ₹16.2 Cr ₹16.21 Cr ₹15.99 Cr ₹15.52 Cr
Other Expenses ₹119.81 Cr ₹111.51 Cr ₹104.71 Cr ₹94.73 Cr ₹95.08 Cr ₹85.26 Cr ₹94.08 Cr ₹81.81 Cr ₹80.85 Cr ₹70.93 Cr ₹73.54 Cr ₹63.74 Cr
Total Expenses ₹468.75 Cr ₹417.19 Cr ₹357.1 Cr ₹323.28 Cr ₹344.56 Cr ₹334.51 Cr ₹328.88 Cr ₹303.67 Cr ₹300.82 Cr ₹269.05 Cr ₹271.27 Cr ₹251.65 Cr
Profit Before Exceptional Items & Tax ₹83.51 Cr ₹102.73 Cr ₹120.73 Cr ₹121.62 Cr ₹120.57 Cr ₹111.51 Cr ₹117.23 Cr ₹98.02 Cr ₹92.23 Cr ₹87.11 Cr ₹80.11 Cr ₹82.29 Cr
Exceptional Items ₹0 -₹6.8 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹74.9 Lakh
Profit Before Tax ₹83.51 Cr ₹95.93 Cr ₹120.73 Cr ₹121.62 Cr ₹120.57 Cr ₹111.51 Cr ₹117.23 Cr ₹98.02 Cr ₹92.23 Cr ₹87.11 Cr ₹80.11 Cr ₹83.04 Cr
Total Tax Expense ₹20.18 Cr ₹26.8 Cr ₹29.89 Cr ₹29.86 Cr ₹31.02 Cr ₹28 Cr ₹30.53 Cr ₹24.42 Cr ₹24.1 Cr ₹22.81 Cr ₹18.76 Cr ₹20.35 Cr
Net Profit ₹65.04 Cr ₹70.81 Cr ₹91.8 Cr ₹93.08 Cr ₹91.83 Cr ₹85.23 Cr ₹87.45 Cr ₹74.04 Cr ₹68.36 Cr ₹65.02 Cr ₹62.19 Cr ₹62.7 Cr
  attributable to Owners ₹66.29 Cr ₹70.93 Cr ₹91.84 Cr ₹93.08 Cr ₹91.83 Cr ₹85.23 Cr ₹87.45 Cr ₹74.04 Cr ₹68.36 Cr ₹65.02 Cr ₹62.19 Cr ₹62.7 Cr
  attributable to NCI -₹1.25 Cr -₹12.13 Lakh -₹3.75 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -
Other Comprehensive Income ₹24.9 Cr ₹22.52 Cr -₹24.39 Lakh -₹68.72 Lakh ₹14.11 Lakh -₹20.08 Lakh ₹8.09 Lakh -₹1.38 Cr -₹8.41 Lakh ₹24.65 Lakh -₹80.71 Lakh -₹23.89 Lakh
Total Comprehensive Income ₹89.94 Cr ₹93.33 Cr ₹91.55 Cr ₹92.4 Cr ₹91.98 Cr ₹85.03 Cr ₹87.54 Cr ₹72.66 Cr ₹68.27 Cr ₹65.26 Cr ₹61.38 Cr ₹62.46 Cr
EBITDA (computed) ₹128.15 Cr ₹137.45 Cr ₹148.63 Cr ₹147.83 Cr ₹143.77 Cr ₹136.34 Cr ₹141.43 Cr ₹120.84 Cr ₹111.55 Cr ₹106.79 Cr ₹98.32 Cr ₹100.31 Cr
Basic EPS ₹6.54 ₹7.00 ₹9.06 ₹9.19 ₹8.92 ₹8.48 ₹9.01 ₹7.71 ₹7.12 ₹6.78 ₹6.48 ₹6.54
Diluted EPS ₹6.53 ₹6.99 ₹9.06 ₹9.17 ₹8.92 ₹8.48 ₹9.01 ₹7.71 ₹7.12 ₹6.77 ₹6.47 ₹6.53
Latest 12 quarters shown of 24 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,662.46 Cr ₹1,601.8 Cr ₹1,307.25 Cr ₹1,068.05 Cr ₹879.36 Cr ₹747.38 Cr ₹646.16 Cr
Other Income ₹119.92 Cr ₹89.77 Cr ₹58.18 Cr ₹36.29 Cr ₹38.73 Cr ₹19.29 Cr ₹18.58 Cr
Total Income ₹1,782.38 Cr ₹1,691.57 Cr ₹1,365.43 Cr ₹1,104.33 Cr ₹918.09 Cr ₹766.67 Cr ₹664.75 Cr
Cost of Materials Consumed ₹538.86 Cr ₹540.88 Cr ₹432.77 Cr ₹394.84 Cr ₹331.28 Cr ₹245.91 Cr ₹207.01 Cr
Purchases of Stock-in-Trade ₹5.04 Cr ₹7.93 Cr ₹7.02 Cr ₹5.21 Cr ₹10.66 Cr ₹3.08 Cr ₹70.55 Lakh
Changes in Inventories -₹13.4 Cr -₹17.04 Cr ₹13.02 Cr -₹15.52 Cr -₹14.1 Cr -₹2.24 Cr -₹7.77 Cr
Employee Benefit Expense ₹313.15 Cr ₹280.08 Cr ₹228.85 Cr ₹188.35 Cr ₹149.89 Cr ₹130.74 Cr ₹127.34 Cr
Finance Costs ₹13.43 Cr ₹11.41 Cr ₹10.74 Cr ₹8.3 Cr ₹3.61 Cr ₹7.91 Cr ₹17.66 Cr
Depreciation & Amortisation ₹97.9 Cr ₹80.84 Cr ₹62.05 Cr ₹55.64 Cr ₹52.54 Cr ₹46.31 Cr ₹39.28 Cr
Other Expenses ₹372.71 Cr ₹344.58 Cr ₹276.07 Cr ₹230.68 Cr ₹189.49 Cr ₹161.56 Cr ₹158.74 Cr
Total Expenses ₹1,327.69 Cr ₹1,248.68 Cr ₹1,030.53 Cr ₹867.51 Cr ₹723.37 Cr ₹593.29 Cr ₹542.96 Cr
Profit Before Exceptional Items & Tax ₹454.7 Cr ₹442.89 Cr ₹334.89 Cr ₹236.83 Cr ₹194.72 Cr ₹173.38 Cr ₹121.78 Cr
Exceptional Items -₹6.8 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹447.89 Cr ₹442.89 Cr ₹334.89 Cr ₹236.83 Cr ₹194.72 Cr ₹173.38 Cr ₹121.78 Cr
Total Tax Expense ₹111.91 Cr ₹111.56 Cr ₹83.17 Cr ₹57.78 Cr ₹48.7 Cr ₹43.87 Cr ₹29.4 Cr
Net Profit ₹335.98 Cr ₹331.33 Cr ₹251.72 Cr ₹179.04 Cr ₹146.02 Cr ₹129.51 Cr ₹92.38 Cr
Other Comprehensive Income ₹22.62 Lakh -₹1.55 Cr -₹84.52 Lakh ₹14.82 Lakh ₹23.71 Lakh ₹10.46 Lakh ₹28.58 Lakh
Total Comprehensive Income ₹336.21 Cr ₹329.79 Cr ₹250.88 Cr ₹179.19 Cr ₹146.25 Cr ₹129.62 Cr ₹92.67 Cr
EBITDA (computed) ₹566.03 Cr ₹535.14 Cr ₹407.69 Cr ₹300.76 Cr ₹250.86 Cr ₹227.61 Cr ₹178.72 Cr
Basic EPS ₹33.15 ₹33.40 ₹26.24 ₹18.67 ₹15.23 ₹14.54 ₹10.47
Diluted EPS ₹33.12 ₹33.39 ₹26.22 ₹18.65 ₹15.22 ₹14.53 ₹10.46
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,549.95 Cr ₹3,140.36 Cr ₹1,821.35 Cr ₹1,537.76 Cr
Non-current Assets ₹1,910.38 Cr ₹1,280.02 Cr ₹1,029.57 Cr ₹782.18 Cr
Current Assets ₹1,639.57 Cr ₹1,860.34 Cr ₹791.78 Cr ₹755.58 Cr
Property, Plant & Equipment ₹1,200.19 Cr ₹1,030.24 Cr ₹811.83 Cr ₹580.12 Cr
Inventories ₹281.34 Cr ₹249.87 Cr ₹193.01 Cr ₹182.8 Cr
Trade Receivables ₹442.25 Cr ₹340.09 Cr ₹259.28 Cr ₹221.02 Cr
Cash & Equivalents ₹5.94 Cr ₹54.85 Lakh ₹2.14 Cr ₹38.28 Lakh
Equity (Net Worth) ₹3,052.71 Cr ₹2,744.22 Cr ₹1,458.25 Cr ₹1,234.12 Cr
Equity Share Capital ₹50.68 Cr ₹50.66 Cr ₹47.99 Cr ₹47.97 Cr
Borrowings (Non-current) ₹2.53 Cr ₹0 ₹1.09 Cr ₹11.56 Cr
Borrowings (Current) ₹245.9 Cr ₹169.86 Cr ₹159.49 Cr ₹122.96 Cr
Total Debt (computed) ₹248.43 Cr ₹169.86 Cr ₹160.58 Cr ₹134.51 Cr
Current Liabilities ₹419.27 Cr ₹341.8 Cr ₹327.53 Cr ₹268.95 Cr
Total Liabilities ₹497.24 Cr ₹396.14 Cr ₹363.1 Cr ₹303.64 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹245.2 Cr ₹236.65 Cr ₹256.1 Cr ₹194.86 Cr ₹126.26 Cr
Investing Cash Flow -₹267.84 Cr -₹1,191.17 Cr -₹237.02 Cr -₹187.22 Cr -₹88.71 Cr
Financing Cash Flow ₹28.03 Cr ₹952.93 Cr -₹17.32 Cr -₹7.89 Cr -₹39.71 Cr
Capital Expenditure ₹295.51 Cr ₹324.99 Cr ₹271.39 Cr ₹237.46 Cr ₹151.8 Cr
Free Cash Flow (computed) -₹50.31 Cr -₹88.34 Cr -₹15.29 Cr -₹42.6 Cr -₹25.54 Cr
Dividends Paid ₹35.43 Cr ₹30.34 Cr ₹28.74 Cr ₹23.97 Cr ₹23.92 Cr
Net Change in Cash ₹5.39 Cr -₹1.59 Cr ₹1.76 Cr -₹25.06 Lakh -₹2.16 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹443.01 Cr ₹418.86 Cr ₹416.54 Cr ₹384.05 Cr ₹420.97 Cr ₹410.94 Cr ₹402.47 Cr ₹367.42 Cr ₹360.93 Cr ₹320.86 Cr ₹319.9 Cr ₹305.56 Cr
Other Income ₹15.12 Cr ₹29.55 Cr ₹33.72 Cr ₹41.1 Cr ₹23.95 Cr ₹21.75 Cr ₹27.24 Cr ₹16.83 Cr ₹15.66 Cr ₹16.56 Cr ₹12.78 Cr ₹13.17 Cr
Total Income ₹458.14 Cr ₹448.41 Cr ₹450.26 Cr ₹425.14 Cr ₹444.92 Cr ₹432.68 Cr ₹429.71 Cr ₹384.26 Cr ₹376.59 Cr ₹337.43 Cr ₹332.68 Cr ₹318.73 Cr
Cost of Materials Consumed ₹136.96 Cr ₹128.82 Cr ₹144.32 Cr ₹128.75 Cr ₹135.12 Cr ₹135.43 Cr ₹145.02 Cr ₹125.3 Cr ₹117.03 Cr ₹111.46 Cr ₹104.88 Cr ₹99.4 Cr
Purchases of Stock-in-Trade ₹1.36 Cr ₹1.58 Cr ₹1.23 Cr ₹85.85 Lakh ₹2.51 Cr ₹3.32 Cr ₹1.21 Cr ₹89.26 Lakh ₹1.35 Cr ₹1.05 Cr ₹2.85 Cr ₹1.77 Cr
Changes in Inventories ₹9.53 Cr ₹4.09 Cr -₹19.46 Cr -₹7.55 Cr ₹6.28 Cr ₹1.48 Cr -₹19.69 Cr -₹5.11 Cr ₹5.69 Cr -₹1.49 Cr ₹5.37 Cr ₹3.47 Cr
Employee Benefit Expense ₹78.1 Cr ₹85.24 Cr ₹82.9 Cr ₹69.93 Cr ₹71.98 Cr ₹72.79 Cr ₹73.04 Cr ₹66.4 Cr ₹62.29 Cr ₹57.06 Cr ₹55.1 Cr ₹54.41 Cr
Finance Costs ₹3.89 Cr ₹3.94 Cr ₹2.78 Cr ₹2.81 Cr ₹2.17 Cr ₹3.13 Cr ₹3.13 Cr ₹2.98 Cr ₹2.93 Cr ₹3.35 Cr ₹2.1 Cr ₹2.36 Cr
Depreciation & Amortisation ₹25.51 Cr ₹25.06 Cr ₹24.15 Cr ₹22.84 Cr ₹21.33 Cr ₹20.83 Cr ₹20.11 Cr ₹18.98 Cr ₹16.16 Cr ₹15.53 Cr ₹15.33 Cr ₹15.04 Cr
Other Expenses ₹95.97 Cr ₹86.86 Cr ₹96.33 Cr ₹90.44 Cr ₹89.03 Cr ₹82.31 Cr ₹89.96 Cr ₹78.74 Cr ₹77.16 Cr ₹68.39 Cr ₹69.11 Cr ₹61.42 Cr
Total Expenses ₹351.33 Cr ₹335.59 Cr ₹332.26 Cr ₹308.08 Cr ₹328.42 Cr ₹319.3 Cr ₹312.78 Cr ₹288.18 Cr ₹282.62 Cr ₹255.34 Cr ₹254.72 Cr ₹237.86 Cr
Profit Before Exceptional Items & Tax ₹106.81 Cr ₹112.82 Cr ₹118.01 Cr ₹117.06 Cr ₹116.5 Cr ₹113.39 Cr ₹116.93 Cr ₹96.08 Cr ₹93.97 Cr ₹82.09 Cr ₹77.96 Cr ₹80.87 Cr
Exceptional Items ₹0 -₹6.8 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹106.81 Cr ₹106.01 Cr ₹118.01 Cr ₹117.06 Cr ₹116.5 Cr ₹113.39 Cr ₹116.93 Cr ₹96.08 Cr ₹93.97 Cr ₹82.09 Cr ₹77.96 Cr ₹80.87 Cr
Total Tax Expense ₹26.18 Cr ₹27.63 Cr ₹28.96 Cr ₹29.14 Cr ₹29.84 Cr ₹28.24 Cr ₹29.71 Cr ₹23.77 Cr ₹23.44 Cr ₹20.63 Cr ₹18.76 Cr ₹20.34 Cr
Net Profit ₹80.62 Cr ₹78.38 Cr ₹89.05 Cr ₹87.93 Cr ₹86.66 Cr ₹85.15 Cr ₹87.22 Cr ₹72.3 Cr ₹70.53 Cr ₹61.46 Cr ₹59.21 Cr ₹60.52 Cr
Other Comprehensive Income ₹62.83 Lakh ₹22.39 Lakh ₹25.18 Lakh -₹87.79 Lakh -₹3.96 Lakh ₹14.97 Lakh -₹36.5 Lakh -₹1.29 Cr -₹12,000 ₹4.96 Lakh -₹79.97 Lakh -₹9.39 Lakh
Total Comprehensive Income ₹81.25 Cr ₹78.61 Cr ₹89.3 Cr ₹87.05 Cr ₹86.62 Cr ₹85.3 Cr ₹86.86 Cr ₹71.01 Cr ₹70.53 Cr ₹61.51 Cr ₹58.41 Cr ₹60.43 Cr
EBITDA (computed) ₹136.21 Cr ₹141.82 Cr ₹144.94 Cr ₹142.72 Cr ₹139.99 Cr ₹137.35 Cr ₹140.17 Cr ₹118.03 Cr ₹113.06 Cr ₹100.97 Cr ₹95.39 Cr ₹98.27 Cr
Basic EPS ₹7.95 ₹7.73 ₹8.79 ₹8.68 ₹8.40 ₹8.48 ₹8.99 ₹7.53 ₹7.35 ₹6.41 ₹6.17 ₹6.31
Diluted EPS ₹7.95 ₹7.72 ₹8.78 ₹8.67 ₹8.40 ₹8.48 ₹8.98 ₹7.53 ₹7.35 ₹6.40 ₹6.17 ₹6.30
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Poly Medicure Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Poly Medicure Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 62.42%, foreign institutional investors hold 5.91%, domestic institutional investors hold 15.59%, retail and other public shareholders hold 16.08% of Poly Medicure Limited. The company had 73,414 shareholders on record.

Promoters: 62.42%DII (Domestic Institutional): 15.59%FII (Foreign Institutional): 5.91%Retail & Others: 16.08%
Mar 2026
QUARTER
62.42% Promoters
15.59% DII (Domestic Institutional)
5.91% FII (Foreign Institutional)
16.08% Retail & Others
Promoter holding - history
Now 62.42% · Mar 2026High 66.03% · Jun 2024Low 44.66% · Mar 2022
43%49.3%55.5%61.8%68%Dec 2015Jun 2018Dec 2020Mar 2023Jun 2025Dec 2015: 48.63%Mar 2016: 48.76%Jun 2016: 48.76%Sep 2016: 48.76%Dec 2016: 48.76%Mar 2017: 48.76%Jun 2017: 48.76%Sep 2017: 48.76%Dec 2017: 48.76%Mar 2018: 48.76%Jun 2018: 48.76%Sep 2018: 48.76%Dec 2018: 48.76%Mar 2019: 48.75%Jun 2019: 48.75%Sep 2019: 48.75%Dec 2019: 48.76%Mar 2020: 48.76%Jun 2020: 48.76%Sep 2020: 48.76%Dec 2020: 48.76%Feb 2021: 44.88%Mar 2021: 44.88%Jun 2021: 44.77%Sep 2021: 44.77%Dec 2021: 44.76%Mar 2022: 44.66%Jun 2022: 53.34%Sep 2022: 53.33%Dec 2022: 53.33%Mar 2023: 53.31%Jun 2023: 53.31%Sep 2023: 53.16%Dec 2023: 53.16%Mar 2024: 53.15%Jun 2024: 66.03%Aug 2024: 62.56%Sep 2024: 62.56%Dec 2024: 62.44%Mar 2025: 62.44%Jun 2025: 62.44%Sep 2025: 62.42%Dec 2025: 62.42%Mar 2026: 62.42%66.03%44.66%62.42%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters62.42%62.42%62.42%62.44%62.44%62.44%
Public37.58%37.58%37.58%37.56%37.56%37.56%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters62.42%62.44%53.15%53.31%44.66%44.88%48.76%48.75%48.76%48.76%48.76%
Public37.58%37.56%46.85%46.69%55.34%55.12%51.24%51.25%51.24%51.24%51.24%
Promoter change (YoY, %pts)-0.02+9.29-0.16+8.65-0.22-3.88+0.01-0.01+0.00+0.00-

Board & Governance of Poly Medicure Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Poly Medicure Limited has 12 directors - 5 independent and 4 executive. The board is chaired by DEVENDRA RAJ MEHTA.

DirectorPositionOn board sinceListed boards
DEVENDRA RAJ MEHTA Non-Executive - Non Independent Director · Chairperson 2014-09-23 1
HIMANSHU BAID Executive Director · MD 1995-04-01 3
RISHI BAID Executive Director 1995-04-01 1
JUGAL KISHORE BAID Non-Executive - Non Independent Director 1995-05-20 1
ALESSANDRO BALBONI Non-Executive - Non Independent Director 2018-05-10 1
AMIT KHOSLA Non-Executive - Independent Director 2020-06-05 1
SONAL MATTOO Non-Executive - Independent Director 2020-08-29 1
AMBRISH MITHAL Non-Executive - Independent Director 2022-08-04 1
VIMAL BHANDARI Non-Executive - Independent Director 2024-07-22 4
VISHAL GUPTA Non-Executive - Independent Director 2024-10-28 2
VISHAL BAID Executive Director 2025-05-06 1
PANKAJ KUMAR GUPTA Executive Director 2025-08-08 1
Board Committees
CommitteeMembers
Audit Committee AMIT KHOSLA (Chairperson), DEVENDRA RAJ MEHTA, VIMAL BHANDARI
Nomination and remuneration committee SONAL MATTOO (Chairperson), DEVENDRA RAJ MEHTA, AMIT KHOSLA
Stakeholders Relationship Committee AMIT KHOSLA (Chairperson), HIMANSHU BAID, RISHI BAID, VISHAL GUPTA
Risk Management Committee SONAL MATTOO (Chairperson), RISHI BAID, HIMANSHU BAID, VIMAL BHANDARI
Corporate Social Responsibility Committee DEVENDRA RAJ MEHTA (Chairperson), JUGAL KISHORE BAID, SONAL MATTOO

Charges & Borrowings of Poly Medicure Limited

Open charges
₹479.5 Cr
Satisfied charges
₹140.2 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹402.00 Cr
Hdfc Bank Limited₹42.50 Cr
Citi Bank N.A.₹25.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹10.00 Cr
Latest charge details
DateLenderAmountStatus
18 Apr 2025 Hdfc Bank Limited ₹30 Cr Open
07 Nov 2017 Hdfc Bank Limited ₹12.5 Cr Open
14 Feb 2017 The Hongkong and Shanghai Banking Corporation Limited ₹10 Cr Open
15 Jun 2011 Citi Bank N.A. ₹25 Cr Open
08 Aug 2002 Sbicap Trustee Company Limited ₹402 Cr Open

Total charge records: 10 View all charges

Employees and EPFO Compliance at Poly Medicure Limited

Poly Medicure Limited has a workforce of 2,683 employees as of Apr 05, 2024.

Employee count
2,683
Active EPFO establishments
9
Employee growth
15.95%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Poly Medicure Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Poly Medicure Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Poly Medicure Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Poly Medicure Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Poly Medicure Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Poly Medicure Limited

MSME Payment Delays by Poly Medicure Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Poly Medicure Limited

Subsidiaries & Group Companies of Poly Medicure Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Poly Medicure Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Poly Medicure Limited

MCA Filings & Documents of Poly Medicure Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Poly Medicure Limited

Charges
12 Feb 2026
A charge with Sbicap Trustee Company Limited of Rs. 402.00 Cr registered on 08 Aug 2002 with Charge ID 90062621 was modified on 12 Feb 2026.
Activity
25 Sep 2025
Poly Medicure Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Directors
08 Aug 2025
Pankaj Kumar Gupta was appointed as a Whole-time director on 08 Aug 2025 & has been associated with this company since 11 months 1 day.
Directors
06 May 2025
Vishal Baid was appointed as a Director on 06 May 2025 & has been associated with this company since 1 year 2 months.
Charges
18 Apr 2025
A charge with Hdfc Bank Limited amounted to Rs. 30.00 Cr with Charge ID 101121003 was registered on 18 Apr 2025.
Activity
31 Mar 2025
Poly Medicure Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.

Recent News on Poly Medicure Limited

Stocks that will see action today: February 3, 2025
03 Feb 2025 · Thehindubusinessline

Frequently Asked Questions about Poly Medicure Limited

Poly Medicure Limited is an active public limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 30 March 1995 (31+ years old) and is registered under CIN L40300DL1995PLC066923. Listed on BSE: 531768 and NSE: POLYMED. The company has 2,683 employees.

Poly Medicure Limited reported revenue of ₹1,758.96 Cr for FY 2025 (up 23.00% YoY).

The current directors of Poly Medicure Limited are:

The primary industry of Poly Medicure Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.

Yes. Poly Medicure Limited is listed on both BSE (code: 531768) and NSE (symbol: POLYMED).

Poly Medicure Limited can be reached at the registered office: Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020, or through the website polymedicure.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available